<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01184703</url>
  </required_header>
  <id_info>
    <org_study_id>GI-project_1</org_study_id>
    <nct_id>NCT01184703</nct_id>
  </id_info>
  <brief_title>Low Glycemic Index Diet in Patients With Type 1 Diabetes</brief_title>
  <acronym>LGID1</acronym>
  <official_title>Effects of a Low Glycemic Index Diet on HbA1c and Lipids in Patients With Type I Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Steno Diabetes Center Copenhagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Steno Diabetes Center Copenhagen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate if a low glycemic index diet in comparison with a&#xD;
      medium/high glycemic index diet improves the metabolic control in patients with type 1&#xD;
      diabetes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The glycemic index (GI) was introduced by Jenkins and co-workers in the early 1980s, and is a&#xD;
      concept for ranking of carbohydrate foods based on their effect on postprandial glycaemia. A&#xD;
      meta-analysis of randomised controlled trials of the effect of low GI diets in the management&#xD;
      of diabetes showed a beneficial effect (i.e., a reduction in HbA1c) of low GI versus high GI&#xD;
      foods. However, several critical points concerning the GI concept remain, for instance, how&#xD;
      to apply it in practical every day life, how to calculate GI in mixed meals, how to find&#xD;
      relevant low GI foods, how to ensure compliance to a low GI diet. The most important issue,&#xD;
      however, is the fact that studies on the long-term effects of a low GI diet in type 1&#xD;
      diabetes are lacking. In this study, the critical issue of finding palatable low GI foods&#xD;
      will be solved in close collaboration with the food industry. This may lead to the&#xD;
      development of new commercial products with low GI, which is necessary if low GI diets are to&#xD;
      be advocated for diabetics in the future.&#xD;
&#xD;
      Comparison(s): A low glycemic index diet, compared to a medium/normal glycemic index diet.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2007</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">August 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>HbA1c</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>LDL-cholesterol</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">65</enrollment>
  <condition>Diabetes Mellitus, Type 1</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Low GI food</intervention_name>
    <description>Comparison of carbohydrates in diabetic patients</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Type I diabetes, durability &gt;5 years&#xD;
&#xD;
          -  Age 20-65 years&#xD;
&#xD;
          -  Normal weight (BMI 19-26 kg/m2)&#xD;
&#xD;
          -  Diabetic treatment with mealtime and bedtime insulin.&#xD;
&#xD;
          -  HbA1c â‰¤10 %&#xD;
&#xD;
          -  Informed consent to participate in the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Diabetic complications; neuropathy, foot ulcers and/or gastroparesis.&#xD;
&#xD;
          -  A known food intolerance of gluten, leguminous plants, nuts or almonds.&#xD;
&#xD;
          -  Pregnancy or breast-feeding.&#xD;
&#xD;
          -  Concurrent participation in another research study with metabolic effects.&#xD;
&#xD;
          -  Previously regular follow-up with a dietician at SDC during the last year.&#xD;
&#xD;
          -  Adjustment during the study of medical treatment other than insulin and/or nutritional&#xD;
             supplement with metabolic effects.&#xD;
&#xD;
          -  Non acceptance of the study diet or food products that are recommended in the study.&#xD;
&#xD;
          -  Disability to read and understand the Danish language.&#xD;
&#xD;
          -  Unable to receive and/or store the test products.&#xD;
&#xD;
          -  Place of residence &gt;1 hr drive from SDC.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Margareta Bensow Bacos, Ch Diet</last_name>
    <role>Principal Investigator</role>
    <affiliation>Steno Diabetes Center Copenhagen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Steno Diabetes Center</name>
      <address>
        <city>Gentofte</city>
        <zip>DK-2820</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>August 2010</verification_date>
  <study_first_submitted>August 17, 2010</study_first_submitted>
  <study_first_submitted_qc>August 18, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 19, 2010</study_first_posted>
  <last_update_submitted>September 2, 2010</last_update_submitted>
  <last_update_submitted_qc>September 2, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 6, 2010</last_update_posted>
  <responsible_party>
    <name_title>Margareta Bensow Bacos</name_title>
    <organization>Steno Diabetes Center</organization>
  </responsible_party>
  <keyword>Diabetes Mellitus, Type 1</keyword>
  <keyword>Glycemic Index Diet</keyword>
  <keyword>HbA1c</keyword>
  <keyword>Lipids</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

